Envoy Medical, Inc. announced an amendment on December 18, 2025, extending the expiration date of 1,125,499 stock purchase warrants from December 31, 2025, to December 31, 2026. The warrants are linked to a minimum exercise price of $1.50 per share, with terms established in a previous equity transaction.